REDUX/PONDIMIN WITHDRAWALS PROVOKE QUESTIONS OF OFF-LABEL USE PROVISIONS IN FDA REFORM BILL; FEN-PHEN CITED IN KENNEDY ATTEMPT TO CHANGE DEVICE PROVISIONS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".